COVID-19 in rheumatic disease patients on immunosuppressive agents

Hematology findings in patients with Coronavirus disease 2019 (COVID-19)

In December 2019, Wuhan, the capital of Hubei Province in China, became the center of an outbreak of pneumonia with unknown etiology. By 7 January 2020, Chinese scientists have isolated a new coronavirus from patients with viral infectious pneumonia, the Coronavirus 2 Acute Respiratory Syndrome (SARS-CoV-2), previously called 2019-nCoV. The disease was later diagnosed as coronavirus 2019 (COVID...

Key words: Rheumatoid arthritis, combination drug therapy, methotrexate, disease-modifying anti-rheumatic drugs, immunosuppressive agents

1Department of Internal Medicine I, 2Institute for Health Economics and Clinical Epidemiology, University Hospital of Cologne, Cologne. Germany. Thomas Rath, MD A. Rubbert, MD Please address correspondence to: Thomas Rath, MD, Department of Internal Medicine I, University Hospital of Cologne, Kerpener Straße 62, 50937 Cologne, Germany. E-mail: [email protected] Received and accepted on Se...

Problems with immunosuppressive agents in renal disease.

The effect of corona disease(COVID-19) on dentistry

کرونا ویروس 2019 یا اصطلاحا COVID-19  بیماری عفونی است  که بسرعت در جهان در حال گسترش است.1 برای اولین بار در31 دسامبر 2019  ، موارد متعددی پنومونی با اتیولوژی نامشخص، درووهان چین (استان (Hubeiگزارش شد.مرکز کنترل و پیشگیری چین نوعی کروناویروس که از لحاظ فیلوژنیک در دسته سارس قرار داشت را عامل بیماری معرفی نمود. COVID-19  توسط Dr  Li  Wenlian شناسایی شد.  این بیماری شدیدا مسری  بسرعت در چین و سر...

Review of Anti-inflammatory and Immunosuppressive Drugs Used in COVID-19 Epidemic

Introduction: Immunosuppressive drugs are classified into different groups depending on the mechanism of action and are used in the control of acute and chronic inflammatory disorders. Considering the possibility of severe inflammatory complications such as acute respiratory failure and cytokine storm in the patients with COVID-19, there is a need to review the updated data on the effectiveness...